MedTrace Logo

Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease

NCT04439747 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-06-23

No results posted yet for this study

Summary

Methods of diagnostic and treatment of hormonal disorders in patients with chronic kidney disease (CKD) will be developed and implemented in real clinical practice. As a result of the project, new scientific data will be obtained on the relationship of hyperprolactinemia and impaired functioning of the pituitary-gonadal axis, changes in functioning of the renin-angiotensin-aldosterone system will be revealed, and the characteristics of the thyroid and parathyroid status in patients with CKD will be determined, including receiving renal replacement therapy (RRT) and after kidney transplantation, which will improve the efficiency of diagnosis and treatment of hormonal disorders in the early stages of the disease, reduce the direct financial costs of the diagnostic and treatment process primarily due to the optimization of hormonal studies and treatment of the revealed disorders, as well as will prevent the progression of CKD and the severity of the condition of this category of patients due to the development of hormonal dysfunctions.

Conditions

  • Hyperprolactinemia
  • Thyroid Dysfunction
  • Bone Diseases, Metabolic
  • Chronic Kidney Diseases

Interventions

OTHER

Ultrasound, DXA, hormonal tests

Diagnostic tests in selected groups with investigation of revealed hormonal disorders

Sponsors & Collaborators

  • Belarusian State Medical University

    lead OTHER

Principal Investigators

  • Tatiana Mokhort, Prof · Head of Endocrinology Department

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439747 on ClinicalTrials.gov